What is the next step if gallstones are still present after percutaneous cholecystectomy (PC) tube placement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Persistent Gallstones After Percutaneous Cholecystostomy Tube Placement

For patients with persistent gallstones after percutaneous cholecystostomy (PC) tube placement, the next step should be definitive stone removal through either endoscopic retrograde cholangiopancreatography (ERCP) with biliary sphincterotomy or laparoscopic cholecystectomy, depending on the patient's surgical risk and clinical status. 1

Assessment of Patient Status

Before deciding on the next intervention, evaluate:

  • Patient's current clinical condition and stability
  • Surgical risk factors (age, comorbidities, frailty)
  • Time since PC tube placement (tract maturation typically takes 4-6 weeks) 1
  • Location of stones (gallbladder vs. common bile duct)
  • Patency of the biliary system (perform cholangiogram via PC tube)

Management Algorithm

Step 1: Perform a Cholangiogram

  • Conduct a cholangiogram through the PC tube 2-3 weeks after placement to assess:
    • Biliary tree patency
    • Stone location and number
    • Cystic duct patency 1

Step 2: Select Appropriate Intervention Based on Patient Status

For Surgically Fit Patients:

  • Laparoscopic cholecystectomy is the definitive treatment of choice after the acute inflammation has resolved 1, 2
  • Should be performed within 4-6 weeks after PC tube placement when the patient has stabilized
  • Consider laparoscopic bile duct exploration (LBDE) if common bile duct stones are present 1

For High-Risk or Elderly Patients:

  • ERCP with biliary sphincterotomy and stone extraction for common bile duct stones 1, 2
  • For gallbladder stones in patients with prohibitive surgical risk:
    • Percutaneous stone extraction via the mature PC tube tract 3, 4
    • Endoscopic cholecystolithotripsy for larger stones 5
    • Stone dissolution therapy with ursodeoxycholic acid (8-10 mg/kg/day) for small radiolucent stones 6

For Patients with Failed ERCP:

  • Percutaneous transhepatic biliary drainage with stone advancement into the duodenum 3
  • Combined percutaneous-endoscopic approach (rendezvous technique) 2

Special Considerations

For Critically Ill Patients:

  • Long-term PC tube drainage may be considered as definitive therapy in patients with terminal disease or prohibitive surgical risk 7, 8
  • PC tube should remain in place for 4-6 weeks to allow tract maturation 1
  • Consider elective biliary sphincterotomy to reduce risk of recurrent biliary events if cholecystectomy is contraindicated 1

For Patients with Altered Anatomy:

  • Patients with Roux-en-Y gastric bypass should be referred to specialized centers for advanced endoscopic and surgical treatment options 1, 2
  • For Billroth II anatomy, consider forward-viewing endoscope for ERCP if a duodenoscope is difficult to use 2

Timing of Intervention

  • For stable patients, definitive treatment should be performed after resolution of acute inflammation
  • Cholecystectomy can be safely performed up to 10 days from symptom onset in elderly patients 1
  • Earlier intervention is associated with shorter hospital stays and fewer complications 1

Potential Complications to Monitor

  • Bile leak after PC tube removal (especially if removed before 4 weeks)
  • Recurrent cholecystitis if stones are not definitively treated
  • Biliary peritonitis
  • Catheter dislodgement
  • Secondary infection of the gallbladder 8

By following this structured approach, patients with persistent gallstones after PC tube placement can receive appropriate definitive management based on their clinical status and surgical risk.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.